Background: Ceftriaxone or cefotaxime has been the drug of choice to treat spontaneous bacterial peritonitis (SBP) for many years, but little is known about microbiology, resistance rate to cephalosporines, and clinical outcomes over the last few decades. Our study aimed to describe the clinical and microbiological characteristics of culture-positive SBP at University of Kentucky Hospital. […]

Background: Spontaneous bacterial peritonitis (SBP) is a commonly encountered complication of end stage liver disease that carries a high morbidity and mortality. Risk factors for SBP are defined by the American Association for the Study of Liver Diseases (AASLD) as a prior history of SBP, active gastrointestinal bleeding, and low ascites total protein (< 1.5 […]